Back
Lumos Pharma 10K Form
Sell
42
LUMO
Lumos Pharma
Last Price:
3.57
Seasonality Move:
-0.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LUMO News And Ratings
See the #1 stock for the next 7 days that we like better than LUMO
LUMO Financial Statistics
Sales & Book Value
Annual Sales: | $2.05M |
---|---|
Cash Flow: | $-6.38M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.26 |
Price / Book: | 2.84 |
Profitability
EPS (TTM): | -4.43000 |
---|---|
Net Income (TTM): | $-35.75M |
Gross Margin: | $934K |
Return on Equity: | -133.22% |
Return on Assets: | -92.04% |
Lumos Pharma Earnings Forecast
Key Lumos Pharma Financial Ratios
- The Gross Profit Margin over the past 2 years for LUMO is 100.00%.
- The Selling, General & Administrative Expenses for LUMO have been equal to 807.85% of Gross Profit Margin.
- The Research & Development expenses have been 1,077.33% of Revenue.
- The Interest Expense is -0.52% of Operating Income.
- Per Share Earnings over the last 16 years have been positive in 6 years.
Lumos Pharma Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | LUMO |
CUSIP: | 55028X |
Website: | lumos-pharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.23 |
Quick Ratio: | 3.44 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
LUMO Technical Analysis vs Fundamental Analysis
Sell
42
Lumos Pharma (LUMO)
is a Sell
Is Lumos Pharma a Buy or a Sell?
-
Lumos Pharma stock is rated a Sell
The current Lumos Pharma [LUMO] share price is $3.59. The Score for LUMO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.